Abstract
Background
Variation in the surgical treatment of melanoma occurs despite efforts to standardize care. This may lead to morbidity, inaccurate staging, and poor outcomes, or it may be cost ineffective. The purpose of our study was to evaluate our institutional compliance with National Comprehensive Cancer Network (NCCN) melanoma treatment guidelines.
Methods
We studied 252 clinically node-negative melanoma patients identified from our cancer registry. Treatment data were confirmed by individual review of pathology and operative reports.
Results
Documented margins of excision conformed to NCCN guidelines in 87% of Tis–T1 tumors and 60% of T2–T4 tumors. Lymph node staging was performed in 11% of T1a, 64% of T1b, 74% of T2, 63% of T3, and 47% of T4 patients. Treatment by a surgical oncologist achieved margin and lymph node compliance in 95% and 92% of cases versus other practitioners in 38% and 67%, respectively (P < .0001). Documented compliance with margin guidelines improved from 46% to 73% for the years 1995 to 1999 versus 2000 to 2004 (P < .0001) and for lymph node staging and treatment from 74% to 84% (P = .04). Other factors associated with greater adherence to NCCN guidelines were patient age <80 years, upper extremity tumors, and thinner tumors (all P < .05).
Conclusions
Our data suggest that our compliance with NCCN melanoma treatment guidelines was suboptimal. Treatment directed by a surgical oncologist showed the highest rate of adherence to national standards. Further investigation is needed to determine the effect of this on patient outcomes and how best to provide high-quality care to the greatest number of melanoma patients.
Similar content being viewed by others
References
Jamal A, Siegel R, Ward E, et al. Cancer Statistics, 2007. CA Cancer J Clin 2007;57:43–66
Veronesi U, Cascinelli N. Narrow excision (1-cm margin): a safe procedure for thin cutaneous melanoma. Arch Surg 1991;126:438–41
Cohn-Cedermark G, Rutqvist LE, Andersson R, et al. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8–2.0 mm. Cancer 2000;89:1495–501
Balch CM, Soong SJ, Smith T, et al. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1–4 mm melanomas. Ann Surg Oncol 2001;8:101–8
Khayat D, Rixe O, Martin G, et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick): long-term results of a large European multicentric phase III study. Cancer 2003;97:1941–6
Thomas JM, Newton-Bishop J, A’Hern R, et al. Excision margins in high-risk malignant melanoma. N Engl J Med 2004;350:757–66
McKinnon JG, Starritt EC, Scolyer RA, et al. Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas ≤2 mm thick. Ann Surg 2005;241:326–33
Thompson JF, Scolyer RA, Uren RF. Surgical management of primary cutaneous melanoma: excision margins and the role of sentinel lymph node examination. Surg Oncol Clin N Am 2006;15:301–18
Lens MB, Dawes M, Goodacre T, et al. Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision. Arch Surg 2002;137:1101–6
Balch CM, Urist MM, Karakousis CP, et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Ann Surg 1993;218:262–9
Hieken TJ. The role of sentinel node biopsy in skin cancer (2nd edition). In: eMedicine Clinical Knowledge Base, Dermatology. Updated May 2006. Available at: http://www.emedicine.com. Accessed March 1, 2007
Morton DL, Thompson JF, Cochran JF, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307–15
NCCN clinical practice guidelines in oncology: melanoma v.2.2006. Available at: http://www.nccn.org/. Accessed August 1, 2006
Haigh PI, Urbach DR. Underuse of wide excision for primary cutaneous melanoma in the United States. Am Surg 2004;70:942–6
Cormier JN, Xing Y, Ding M, et al. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol 2005;23:6054–62
Sitzenberg KB, Thomas NE, Beskow LM, et al. Population-based analysis of lymphatic mapping and sentinel lymphadenectomy utilization for intermediate thickness melanoma. J Surg Oncol 2006;93:100–8
Scott JD, McKinley BP, Bishop A, et al. Treatment and outcomes of melanoma with a Breslow’s depth greater than or equal to one millimeter in a regional teaching hospital. Am Surg 2005;71:198–201
Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004;150:179–85
Acknowledgments
Supported in part by the Surgical Research Fund of the Rush North Shore Medical Center Department of Surgery and the Department of General Surgery, Rush University Medical Center. Presented as a poster at the Society of Surgical Oncology 60th Annual Cancer Symposium, Washington, DC, March 16, 2007.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Erickson, J.L., Velasco, J.M. & Hieken, T.J. Compliance with Melanoma Treatment Guidelines in a Community Teaching Hospital: Time Trends and Other Variables. Ann Surg Oncol 15, 1211–1217 (2008). https://doi.org/10.1245/s10434-007-9789-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-007-9789-6